These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1959887)

  • 1. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy.
    Zifroni A; Schaffner F
    Hepatology; 1991 Dec; 14(6):990-3. PubMed ID: 1959887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective trial of colchicine for primary biliary cirrhosis.
    Kaplan MM; Alling DW; Zimmerman HJ; Wolfe HJ; Sepersky RA; Hirsch GS; Elta GH; Glick KA; Eagen KA
    N Engl J Med; 1986 Dec; 315(23):1448-54. PubMed ID: 3537784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
    Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
    Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of colchicine therapy in primary biliary cirrhosis.
    Bodenheimer H; Schaffner F; Pezzullo J
    Gastroenterology; 1988 Jul; 95(1):124-9. PubMed ID: 3286360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
    Kaplan MM; Cheng S; Price LL; Bonis PA
    Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of primary biliary cirrhosis with p-tolylmethylcarbinol nicotinic acid ester in combination with alpha-naphthylacetic acid.
    Kaserbacher R; Propst A; Vogel W
    Wien Klin Wochenschr; 1996 Nov; 108(22):722-6. PubMed ID: 8986034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
    Raedsch R; Stiehl A; Walker S; Scherrmann JM; Kommerell B
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():55-7. PubMed ID: 1449019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of long-term ursodiol treatment for patients with primary biliary cirrhosis.
    Jorgensen R; Angulo P; Dickson ER; Lindor KD
    Am J Gastroenterol; 2002 Oct; 97(10):2647-50. PubMed ID: 12385454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
    Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
    Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cirrhosis with colchicine. A double-blind randomized trial.
    Kershenobich D; Uribe M; Suárez GI; Mata JM; Pérez-Tamayo R; Rojkind M
    Gastroenterology; 1979 Sep; 77(3):532-6. PubMed ID: 378754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
    Batts KP; Jorgensen RA; Dickson ER; Lindor KD
    Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation.
    Balan V; Batts KP; Porayko MK; Krom RA; Ludwig J; Wiesner RH
    Hepatology; 1993 Dec; 18(6):1392-8. PubMed ID: 8244263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective trial of D-penicillamine in primary biliary cirrhosis.
    Matloff DS; Alpert E; Resnick RH; Kaplan MM
    N Engl J Med; 1982 Feb; 306(6):319-26. PubMed ID: 7033789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine.
    Miettinen TA; Färkkilä M; Vuoristo M; Karvonen AL; Leino R; Lehtola J; Friman C; Seppälä K; Tuominen J
    Hepatology; 1995 May; 21(5):1261-8. PubMed ID: 7737632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.